Table 3.
Comparison of patients who had improvement of their HbA1c between Visit A and Visit B
| Improvement in HbA1c (n = 269) | No improvement in HbA1c (n = 235) | P‐value | |
|---|---|---|---|
| Age ± SD (years) | 58.9 ± 15.7 | 60.1 ± 16.6 | 0.423 |
| Type 2 diabetes, n (%) | 220 (81.8) | 192 (81.7) | 0.981 |
| Requirement of insulin therapy, n (%) | 210 (78.4) | 174 (74.0) | 0.257 |
| Known cardiovascular disease, n (%) | 80 (29.9) | 84 (35.7) | 0.160 |
| Need for interpreters, n (%) | 64 (23.8) | 63 (26.8) | 0.436 |
| Anglo‐European background, n (%) | 133 (49.4) | 126 (53.6) | 0.351 |
| BGL records available to clinicians, n (%) | 75 (27.9) | 42 (17.9) | 0.008 |
BGL, blood glucose level.